Moreover, these PNOC-expressing B-cells upregulate the key transcription factor XBP1, which is essential for B cell fate decisions (germinal center vs. plasma cell) and the generation of high-affinity, tumor-targeting antibodies (Fig. 1K). Here, XBP1 is linked to neoplasm.